Korean J Gastroenterol.  2011 Sep;58(3):133-138. 10.4166/kjg.2011.58.3.133.

Preclinical Experience in Stem Cell Therapy for Digestive Tract Diseases

• Jeon MS
• Hong SS

• KMID: 1018400
• DOI: http://doi.org/10.4166/kjg.2011.58.3.133

Abstract

Adult stem cells are multipotent and self-renewing cells that contain several functions; i) migration and homing potential: stem cells can migrate to injured and inflamed tissues. ii) differentiation potential: stem cells which migrated to injured tissues can be differentiated into multiple cell types for repairing and regenerating the tissues. iii) immunomodulatory properties: stem cells, especially mesenchymal stem cells can suppress immune system such as inflammation. All those characteristics might be useful for the treatment of the digestive tract diseases which are complex and encompass a broad spectrum of different pathogenesis. Preclinical stem cell therapy showed some promising results, especially in liver failure, pancreatitis, sepsis, and inflammatory bowel disease. If we can understand more about the mechanism of stem cell action, stem cell therapy can become a promising alternative treatment for refractory digestive disease in the near future. In this review, we summarized current preclinical experiences in diseases of the digestive tract using stem cells.

Keyword

Stem cells; Digestive tract; Liver failure; Pancreatitis

MeSH Terms

Adult Stem Cells/cytology/*transplantation
Digestive System Diseases/*therapy
Drug Evaluation, Preclinical
Humans